iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.80−0.00 (-0.11%)
Close on Nov 20, 2026Market cap $51.45MP/E –Yield –
iBio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
iBio's free cash flow for the twelve months ending Sep 30, 2026 was -$27.59M. For fiscal 2026 it was -$23.80M. The highest annual figure on record is -$4.12M in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$23.80M | – |
| FY2025 | Jun 30, 2025 | -$15.32M | – |
| FY2024 | Jun 30, 2024 | -$18.76M | – |
| FY2023 | Jun 30, 2023 | -$36.17M | – |
| FY2022 | Jun 30, 2022 | -$44.81M | – |
| FY2021 | Jun 30, 2021 | -$34.98M | – |
| FY2020 | Jun 30, 2020 | -$14.42M | – |
| FY2019 | Jun 30, 2019 | -$14.90M | – |
| FY2018 | Jun 30, 2018 | -$14.41M | – |
| FY2017 | Jun 30, 2017 | -$14.49M | – |
| FY2016 | Jun 30, 2016 | -$8.14M | – |
| FY2015 | Jun 30, 2015 | -$4.74M | – |
| FY2014 | Jun 30, 2014 | -$4.12M | – |
| FY2013 | Jun 30, 2013 | -$4.86M | – |
| FY2012 | Jun 30, 2012 | -$6.01M | – |
| FY2011 | Jun 30, 2011 | -$5.34M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$9.49M | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$6.25M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$6.10M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$5.76M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$5.70M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$4.62M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$3.12M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$3.87M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$3.72M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$5.06M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$3.65M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$5.48M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$3.67M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$10.59M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$16.44M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$14.93M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$6.59M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$9.74M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$8.34M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$9.41M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$7.49M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$4.67M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$3.86M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$3.61M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$2.29M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$4.54M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$4.26M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$5.04M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$1.05M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$3.60M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$3.94M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$3.77M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$3.11M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$4.28M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$3.83M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$3.70M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$2.67M | – |
See a number that looks wrong?